Opendata, web and dolomites

CELLPHASE_AD SIGNED

Genetics to understand cellular components of Alzheimer Disease pathogenesis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CELLPHASE_AD project word cloud

Explore the words cloud of the CELLPHASE_AD project. It provides you a very rough idea of what is the project "CELLPHASE_AD" about.

wild    crisper    understudied    answer    risk    patient    single    profiles    accelerated    population    generate    isogenic    insights    inducible    disease    time    hypotheses    axis    stem    transplanted    largely    genetic    validating    mice    pathology    humanized    mouse    pathological    capture    arm    putative    brain    worldwide    genomic    first    tau    vitro    scores    engineered    600    expressed    therapies    manipulate    pathogenesis    chimeric    rodent    establishes    genetics    health    expression    astroglia    polygenic    dynamic    possibilities    human    platform    followed    translation    context    cas9    extensive    neuron    lines    transcriptomics    inflammation    complexity    mechanistic    patients    explore    versatile    linked    cell    gt    progression    vivo    genes    validate    drug    cells    influences    makeup    cholesterol    provides    bioinformatics    ips    models    ad    centric    classically    limitations    beta    phenotypes    view    alzheimer    microglia   

Project "CELLPHASE_AD" data sheet

The following table provides information about the project.

Coordinator
VIB 

Organization address
address: RIJVISSCHESTRAAT 120
city: ZWIJNAARDE - GENT
postcode: 9052
website: www.vib.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 2˙374˙997 €
 EC max contribution 2˙374˙997 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-ADG
 Funding Scheme ERC-ADG
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2024-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIB BE (ZWIJNAARDE - GENT) coordinator 2˙374˙997.00

Map

 Project objective

Alzheimer disease (AD) is a major health problem worldwide. New therapies require an accelerated translation of genetic information into mechanistic insights. Given limitations of rodent models, fully humanized models are needed to capture the complexity of the disease process. Human stem cells (iPS) provide great possibilities but are largely investigated in vitro with associated limitations. Many of the novel genetic risk factors for AD are expressed in microglia and astroglia, which remains an understudied population in this classically neuron-centric field. We propose here mouse-human chimeric mouse models to test the effects of AD-associated genetic risk factors on the phenotypes of transplanted microglia and astroglia derived from patients and from genomic engineered, isogenic stem cells. The cells will be followed during disease progression in brain of wild type and of mice developing Aβ- and Tau- pathology. Using single cell transcriptomics, a dynamic view of the cell states over time is generated. In a first arm of the project, we investigate how the genetic makeup of patient derived stem cells with high and low polygenic risk scores influences pathological cell states. In the second arm of the project, we generate inducible Crisper/CAS9 iPS isogenic cell lines to manipulate rapidly and specifically the expression of 4 selected AD associated genes linked to a putative cholesterol pathway but also affecting inflammation. These cell lines will be used also in the second phase of the project when validating hypotheses generated from the extensive bioinformatics analysis of the 600.000 single human cell profiles generated. We expect to identify and validate >5 novel drug targets in the astroglia-microglia axis of AD pathogenesis. Our work provides humanized models for AD, an answer on how genetic makeup affects microglia and astroglia in an AD relevant context, and establishes a highly versatile platform to explore human genetics in human cells in vivo.

 Publications

year authors and title journal last update
List of publications.
2019 Renzo Mancuso, Johanna Van Den Daele, Nicola Fattorelli, Leen Wolfs, Sriram Balusu, Oliver Burton, Adrian Liston, Annerieke Sierksma, Yannick Fourne, Suresh Poovathingal, Amaia Arranz-Mendiguren, Carlo Sala Frigerio, Christel Claes, Lutgarde Serneels, Tom Theys, V. Hugh Perry, Catherine Verfaillie, Mark Fiers, Bart De Strooper
Stem-cell-derived human microglia transplanted in mouse brain to study human disease
published pages: 2111-2116, ISSN: 1097-6256, DOI: 10.1038/s41593-019-0525-x
Nature Neuroscience 22/12 2019-12-16

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CELLPHASE_AD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CELLPHASE_AD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

Resonances (2019)

Resonances and Zeta Functions in Smooth Ergodic Theory and Geometry

Read More  

Aware (2019)

Aiding Antibiotic Development with Deep Analysis of Resistance Evolution

Read More  

SmartForests (2020)

Smart Forests: Transforming Environments into Social-Political Technologies

Read More